GGrantIndex
Sort

261,768 grants matching gene therapy

Structural basis for the functions of dopamine receptors, neurotransmitter transporters, and sigma 1 receptor

$1,793,708
Lei Shi · National Institute On Drug Abuse · ZIA · FY2021 · DA

Genetics, Pathophysiology, and Treatment of Recessive Autoinflammatory Diseases

$1,793,687
Daniel Kastner · National Human Genome Research Institute · ZIA · FY2019 · HG

Molecular Diagnostics Core Laboratory

$1,793,683
Mark Raffeld · Division Of Basic Sciences - Nci · ZIC · FY2016 · CA

Molecular and Clinical Manifestations of Matrix and Aggregate Myopathies

$1,793,609
Carsten Bonnemann · National Institute Of Neurological Disorders And Stroke · ZIA · FY2020 · NS

Translational Approaches to Develop Drug Therapy for Diarrhea

$1,793,568
Mark Donowitz · Johns Hopkins University · R24 · FY2014 · DK

Spastic Paraplegia Centers of Excellence Research Network (SP-CERN) - RDCRC

$1,793,539
Darius Ebrahimi-Fakhari · Boston Children'S Hospital · U54 · FY2025 · NS

Chromatin Remodeling and Gene Activation

$1,793,496
David J Clark · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2025 · HD

Mechanisms of transcription pausing and fidelity in prokaryotes and eukaryotes

$1,793,476
Mikhail Kashlev · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

CHEMOPREVENTION FOR WOMEN AT HIGH RISK OF BREAST CANCER

$1,793,476
University Of Kansas Medical Center · U01 · FY2002 · CA

Maximizing Local Access to Therapeutic Deliveries in Glioblastoma

$1,793,324
Waldemar Debinski · Wake Forest University Health Sciences · P01 · FY2017 · CA

Prospective tReatment EffiCacy in IPF uSlng genOtype for Nac Selection (PRECISIONS) trial and Molecular Endophenotyping in Idiopathic Pulmonary Fibrosis and Interstitial Lung Diseases study

$1,793,103
Catherine A Spino · University Of Michigan At Ann Arbor · U24 · FY2022 · HL

STEM CELL THERAPY OF CONGENITAL DEFECTS IN HEMATOPOIESIS

$1,793,037
Dana-Farber Cancer Institute · P50 · FY2003 · HL

Retrovirus Models of Cancer

$1,792,351
Patrick Lee Green · Ohio State University · P01 · FY2016 · CA

Identification of cancer stem cell therapeutic targets

$1,792,219
Michael Clarke · Stanford University · P01 · FY2010 · CA

Regulatory and epigenetic landscapes in biological discovery, diagnostics and disease mechanisms

$1,792,057
Laura L Elnitski · National Human Genome Research Institute · ZIA · FY2018 · HG

CAREER: Structural Interplay Between Chromatin Remodeling and Lentiviral Integration

$1,792,054
Dmitry Lyumkis · The Salk Institute For Biological Studies · · FY2021 · BIO

Molecular Determinants of Chromosome Transmission and Cell Cycle Regulation

$1,791,773
Munira Basrai · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Targeting Pathways Involved in Cardiac Injury for Novel Repair Strategies

$1,791,623
Walter J Koch · Duke University · P01 · FY2024 · HL

Utility of Biomarkers of Rejection and Kidney Injury in Tailoring Liver Transplant Immunosuppression

$1,791,523
Josh Levitsky · Northwestern University At Chicago · U01 · FY2022 · AI

Circuit-based deep brain stimulation for Parkinson's disease

$1,791,322
Jerrold L Vitek · University Of Minnesota · P50 · FY2020 · NS

Roles of Chromatin-modifying Factors in Epigenetic Control of the Genome

$1,791,288
Shivinder S Grewal · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

RNAi and Epigenetic Control of Higher-Order Chromatin Assembly

$1,791,288
Shivinder S Grewal · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Core Support for Cancer Center

$1,791,152
Israel David Goldman · Albert Einstein College Of Medicine, Inc · P30 · FY2018 · CA

Elafin Therapy for Pulmonary Arterial Hypertension

$1,790,971
Marlene Rabinovitch · Stanford University · P01 · FY2017 · HL

Retrovirus Models of Cancer

$1,790,956
Patrick Lee Green · Ohio State University · P01 · FY2014 · CA